|
African-American Heart Failure Trial Clinical Trials Information presented on Clinical Trials Search is not designed to be a substitute for proven healthcare advice, travels to or treatment by using a genuine medical doctor. We are not physicians. Always confer with your doctor on African-American Heart Failure Trial conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. African-American Heart Failure Trial Clinical research trials and African-American Heart Failure Trial healthcare trials take place in many of cities across the United States of America. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally evaluate the effectiveness of new drugs. The function of the studies / undertakings is to answer specific human medical questions. Clinical trials are a popular means for mDs, government agencies, and private sector companies to find treatments for all forms of conditions, including African-American Heart Failure Trial. African-American Heart Failure Trial Clinical Trials and other clinical trials allow for volunteers to access medical treatment alternatives before they are available to the masses. Many times the test subjects undergo treatment for without cost, and occasionally they are compensated for their time. Occasionally there is a cost for a African-American Heart Failure Trial clinical trial. Test subjects oftentimes recieve the best healthcare possible for their African-American Heart Failure Trial condition. Hazards are a reality, nonetheless, and might include additional or frequent doctor trips, healthcare hazards (perhaps life-jeopardizing), and/or the treatment being ineffective. Trials are federally regulated with rigid guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "A" Clinical Trials Conditions > African-American Heart Failure Trial  African-American Heart Failure Trial
African-American Heart Failure Trial
For Condition: Congestive Heart Failure
Status: Recruiting
Sponsor(s): Nitromed ,
Synopsis: A placebo-controlled trial of BiDil added to standard therapy in African-American patients with heart failure.
Details: The overall objective is confirmation of BiDil’s Safety and Efficacy in African-American (AFA) Patients with Moderate to Severe Symptomatic Heart Failure.
Eligibility:
Study Type: Interventional, Treatment, Randomized, Double-Blind, Placebo Control, Single Group Assignment, Safety/Efficacy Study
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: - African American male or female 18 years or older. - NYHA Class 3 & 4. - Have either a resting LVEF less than or equal to 35% (by any method) or a resting LVIDD greater than 2.9 cm/m2 BSA (or greater than 6.5 cm) with LVEF less than 45% (by echocardiogram).
Total Enrollment: 1100
Location and Contact Information:
Overall Study Official:
AnneTaylor, Study Chair, University of Minnesota
Cooper Green Hospital *Recruiting*
Birmingham, Alabama, 35233
United States
Recruiting Chris Dease 205-930-3292
Saint Vincents Hospital and Medical Center *Recruiting*
New York City, New York, 10011
United States
Recruiting Robin Giordano 202-604-2215
Cardiology and Medicine Clinic *Recruiting*
Little Rock, Arkansas, 72204
United States
Recruiting Cindy Foley 501-664-0941
Miami International Cardiology Consultants *Recruiting*
Aventura, Florida, 33180
United States
Recruiting Jose Miranda 305-672-1111
Howard University Hospital *Recruiting*
Washington D.C., District of Columbia, 20060
United States
Recruiting Vincent Onyewuotu 202-865-1966
Boston Medical Center *Recruiting*
Boston, Massachusetts, 02118
United States
Recruiting Lorraine Keane 617-638-8757
Minneapolis VA Medical Center *Recruiting*
Minneapolis, Minnesota, 55417
United States
Recruiting Susan Ziesche 612-727-5998
Additional Information:
Study ID Numbers: A-HeFT;
Study Start Date: May 2001
Record last reviewed: August 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00047775
Other Congestive Heart Failure Studies:
1. Autologous Cultured Myoblasts (BioWhittaker) Transplanted via Myocardial Injection
2. Oxypurinol compared with Placebo for Class III-IV NYHA Congestive Heart Failure
3. MYOHEARTâ„¢ (Myogenesis Heart Efficiency and Regeneration Trial)
4. Multicenter, Randomized, Double-Blind, Placebo Controlled, Efficacy Study on the Effects of Tolvaptan on Left Ventricular Dilatation in Congestive Heart Failure Patients
5. Rosiglitazone to Treat Patients with Heart Failure and Glucose Intolerance or Type II Diabetes
Related Studies:
Other Congestive Heart Failure Clinical Trials
Other Arkansas Clinical Trials
Other Little Rock Clinical Trials
African-American Heart Failure Trial
|
|
|
|
|
|
|
|
